Roivant Sciences Ltd Investor Event on Brepocitinib Transcript - Thomson StreetEvents

Roivant Sciences Ltd Investor Event on Brepocitinib Transcript

Roivant Sciences Ltd Investor Event on Brepocitinib Transcript - Thomson StreetEvents
Roivant Sciences Ltd Investor Event on Brepocitinib Transcript
Published Jun 17, 2025
20 pages (13423 words) — Published Jun 17, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROIV.OQ corporate analyst meeting

  
Brief Excerpt:

...Good morning, and thanks for joining today's Brepocitinib investor call. We expect this call to run for approximately 60 minutes to 75 minutes, with prepared remarks around 40 minutes to 45 minutes and the remainder spent on Q&A. Presenting today, we have Matt Gline, CEO of Roivant; and Ben Zimmer, CEO of Priovant. You can find the slides being presented today on our IR website at www.investor.roivant.com. I would like to remind you that we'll be making certain forward-looking statements during today's presentation. We strongly encourage you to review the information that we have filed with the SEC for more information regarding these forward-looking statements and related risks and uncertainties. And with that, I'll turn it over to Matt. Matthew Gline ...

  
Report Type:

Transcript

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd at Cantor Global Healthcare Conference Summary – 2025-09-03 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 3-Sep-25 12:35pm GMT

Roivant Sciences Ltd at Cantor Global Healthcare Conference Transcript – 2025-09-03 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 3-Sep-25 12:35pm GMT

Roivant Sciences Ltd Q1 2025 Earnings Call Summary – 2025-08-11 – US$ 54.00 – Edited Brief of ROIV.OQ earnings conference call or presentation 11-Aug-25 12:00pm GMT

Roivant Sciences Ltd Q1 2025 Earnings Call Transcript – 2025-08-11 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 11-Aug-25 12:00pm GMT

Roivant Sciences Ltd Investor Event on Brepocitinib Summary – 2025-06-17 – US$ 54.00 – Edited Brief of ROIV.OQ corporate analyst meeting</ 17-Jun-25 5:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Summary – 2025-06-10 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary – 2025-06-05 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 5-Jun-25 11:20pm GMT

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Transcript – 2025-06-05 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 5-Jun-25 11:20pm GMT

Roivant Sciences Ltd Q4 2024 Earnings Call Summary – 2025-05-29 – US$ 54.00 – Edited Brief of ROIV.OQ earnings conference call or presentation 29-May-25 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd Investor Event on Brepocitinib Transcript" Jun 17, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-Investor-Event-on-Brepocitinib-T16406677>
  
APA:
Thomson StreetEvents. (2025). Roivant Sciences Ltd Investor Event on Brepocitinib Transcript Jun 17, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-Investor-Event-on-Brepocitinib-T16406677>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.